Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma

Gastroenterol Hepatol. 2019 Apr;42(4):271-279. doi: 10.1016/j.gastrohep.2018.11.003. Epub 2018 Dec 21.
[Article in English, Spanish]

Abstract

Cholangiocarcinomas are heterogeneous biliary tract tumors that cause devastating disease. Perihilar cholangiocarcinoma (PHC) is the most common type of biliary tract cancer and are associated with a high mortality. Diagnoses of PHC depend on the results of its clinical presentation, serum biomarkers and imaging techniques. Pre-operative managements including pre-operative biliary drainage (PBD) and portal vein embolization (PVE) could reduce mortality. The best chance of long-term survival and potential cure is surgical resection with negative surgical margin. Lymph node metastasis over N2 nodes precludes long-term survival. The benefit of concomitant vascular resection remains uncertain. Liver transplantation combined with neoadjuvant chemotherapy with radiotherapy is a promising option in highly selected patients with unresectable tumors. Herein, an overview is provided of developments in diagnosis, peri-operative management and surgical treatment among patients with PHCs.

Keywords: Colangiocarcinoma perihiliar; Diagnosis; Diagnóstico; Perihilar cholangiocarcinoma; Resección quirúrgica; Review; Revisión; Surgical resection.

Publication types

  • Review

MeSH terms

  • Bile Duct Neoplasms / diagnosis*
  • Bile Duct Neoplasms / surgery*
  • Biliary Tract Surgical Procedures / methods
  • Humans
  • Klatskin Tumor / diagnosis*
  • Klatskin Tumor / surgery*
  • Preoperative Care